Evidence map›Paper›PMID 30473646›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2017

Applications of Metabolomics in the Study and Management of Preeclampsia; A Review of the Literature.

Rachel S Kelly, Rachel T Giorgio, Bo L Chawes, Natalia I Palacios, Kathryn J Gray, Hoooman Mirzakhani, Ann Wu, Kevin Blighe, Scott T Weiss, Jessica Lasky-Su

Open access · greenAbstract read
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Metabolomic prediction of severe maternal and newborn complications in preeclampsia.Metabolomics : Official journal of the Metabolomic Society · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Metabolomics in the study of spontaneous animal diseases.Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc · 2020
    Review
  14. 4-Hydroxyglutamate is a novel predictor of pre-eclampsia.International journal of epidemiology · 2020
    Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Rachel S Kelly *Channing Division of Network Medicine, Brigham and Women's Hospital Harvard Medical School, Boston MA 02115, USA.ORCID 0000-0003-3023-1822
Rachel T Giorgio *Channing Division of Network Medicine, Brigham and Women's Hospital Harvard Medical School, Boston MA 02115, USA.
Bo L ChawesChanning Division of Network Medicine, Brigham and Women's Hospital Harvard Medical School, Boston MA 02115, USA.
Natalia I PalaciosDepartment of Public Health University of Massachusetts, Lowell, Lowell MA.
Kathryn J GrayDivision of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA 02115, USA.
Hoooman MirzakhaniChanning Division of Network Medicine, Brigham and Women's Hospital Harvard Medical School, Boston MA 02115, USA.
Ann WuBoston Children's Hospital.
Kevin BligheChanning Division of Network Medicine, Brigham and Women's Hospital Harvard Medical School, Boston MA 02115, USA.
Scott T WeissChanning Division of Network Medicine, Brigham and Women's Hospital Harvard Medical School, Boston MA 02115, USA.
Jessica Lasky-SuChanning Division of Network Medicine, Brigham and Women's Hospital Harvard Medical School, Boston MA 02115, USA.
Brigham and Women's Hospital · USHarvard University · USBoston Children's Museum · USUniversity of Massachusetts Lowell · US

Funding

Integrative Metabolomics of Asthma SeverityR01HL123915 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LASKY-SU, JESSICA A · 2014 to 2023
$7.0M
Mechanistic insights into asthma pathogenesis through the integration of asthma genes, risk exposures, and metabolomicsR01HL141826 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LASKY-SU, JESSICA A · 2018 to 2021
$3.4M
Age-Dependent Pharmacogenomics of Asthma Treatment (ADAPT)R01HD085993 · NICHD · HARVARD PILGRIM HEALTH CARE, INC. · PI WU, ANN CHEN · 2016 to 2020
$3.1M
Longitudinal metabolic profiling throughout gestation in the plasma and urine of women who develop early-onset preeclampsiaF32HD086948 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI GRAY, KATHRYN JOHNSON · 2016 to 2017
$76k
NHLBI NIH HHS R01 HL123915NHLBI NIH HHS R01 HL141826NICHD NIH HHS F32 HD086948NICHD NIH HHS R01 HD085993
6 · The paper itself

Abstract

Introduction: Preeclampsia represents a major public health burden worldwide, but predictive and diagnostic biomarkers are lacking. Metabolomics is emerging as a valuable approach to generating novel biomarkers whilst increasing the mechanistic understanding of this complex condition. Objectives: To summarize the published literature on the use of metabolomics as a tool to study preeclampsia. Methods: PubMed and Web of Science were searched for articles that performed metabolomic profiling of human biosamples using either Mass-spectrometry or Nuclear Magnetic Resonance based approaches and which included preeclampsia as a primary endpoint. Results: Twenty-eight studies investigating the metabolome of preeclampsia in a variety of biospecimens were identified. Individual metabolite and metabolite profiles were reported to have discriminatory ability to distinguish preeclamptic from normal pregnancies, both prior to and post diagnosis. Lipids and carnitines were among the most commonly reported metabolites. Further work and validation studies are required to demonstrate the utility of such metabolites as preeclampsia biomarkers. Conclusion: Metabolomic-based biomarkers of preeclampsia have yet to be integrated into routine clinical practice. However, metabolomic profiling is becoming increasingly popular in the study of preeclampsia and is likely to be a valuable tool to better understand the pathophysiology of this disorder and to better classify its subtypes, particularly when integrated with other omic data.

Indexed as

carnitineshypertensionlipid dysregulationmetabolomicspreeclampsiapregnancy

Identifiers

PMID30473646
PMCPMC6247796
OpenAlexW2622408769

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.